Advanced search
Publication Cover
Scandinavian Cardiovascular Journal Volume 50, 2016 - Issue 1
Submit an article Journal homepage
402
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Stromal cell-derived factor 1α (SDF-1α): A marker of disease burden in patients with atrial fibrillation

Dana LiDepartment of Cardiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, DenmarkCorrespondence[email protected]
,
Louise BjørnagerDepartment of Cardiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
,
Anne LangkildeClinical Research Centre, Hvidovre Hospital, Hvidovre, Denmark
,
Ove AndersenClinical Research Centre, Hvidovre Hospital, Hvidovre, Denmark
,
Christian JønsDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
,
Bue F. R. AgnerDepartment of Cardiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
,
Ulrik DixenDepartment of Cardiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
&
Nadia L. LandexDepartment of Cardiology, Roskilde University Hospital, Roskilde, Denmark
 show all
Pages 36-41 | Received 02 May 2015, Accepted 01 Oct 2015, Published online: 29 Oct 2015

References

  • Bromage DI, Davidson SM, Yellon DM. Stromal derived factor 1alpha: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther. 2014;143:305–315.
  • Penn MS, Pastore J, Miller T, et al. SDF-1 in myocardial repair. Gene Ther. 2012;19:583–587.
  • Zaruba MM, Franz WM. Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy. Expert Opin Biol Ther. 2010;10:321–335.
  • Wojakowski W, Tendera M, Zebzda A, et al. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J. 2006;27:283–289.
  • Stellos K, Rahmann A, Kilias A, et al. Expression of platelet-bound stromal cell-derived factor-1 in patients with non-valvular atrial fibrillation and ischemic heart disease. J Thromb Haemost. 2012;10:49–55.
  • Goette A, Jentsch-Ullrich K, Lendeckel U, et al. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide? Circulation. 2003;108:2446–2449.
  • Burstein B, Qi XY, Yeh YH, et al. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res. 2007;76:442–452.
  • Kim SK, Pak HN, Park JH, et al. Serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Korean Circ J. 2010;40:185–190.
  • Subramanian S, Liu C, Aviv A, et al. Stromal cell-derived factor 1 as a biomarker of heart failure and mortality risk. Arterioscler Thromb Vasc Biol. 2014;34:2100–2105.
  • Pompei P, Charlson ME, Ales K, et al. Relating patient characteristics at the time of admission to outcomes of hospitalization. J Clin Epidemiol. 1991;44:1063–1069.
  • Zoni-Berisso M, Lercari F, Carazza T, et al. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213–220.
  • Qvist JF, Sorensen PH, Dixen U. Hospitalisation patterns change over time in patients with atrial fibrillation. Dan Med J. 2014;61:A4765.
  • Steinberg BA, Kim S, Fonarow GC, et al. Drivers of hospitalization for patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014;167:735–742.
  • Jorbenadze R, Schleicher E, Bigalke B, et al. Expression of platelet-bound stromal-cell derived factor-1 (SDF-1) and number of CD34 progenitor cells in patients with congestive heart failure. Platelets. 2014;25:409–415.
  • Kim SK, Pak HN, Park JH, et al. Non-ischaemic titrated cardiac injury caused by radiofrequency catheter ablation of atrial fibrillation mobilizes CD34-positive mononuclear cells by non-stromal cell-derived factor-1alpha mechanism. Europace. 2009;11:1024–1031.
  • Popple A, Durrant LG, Spendlove I, Rolland P, et al. The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br J Cancer. 2012;106:1306–1313.
  • Kryczek I, Lange A, Mottram P, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 2005;65:465–472.
  • Sasaki T, Fukazawa R, Ogawa S, et al. Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr Int. 2007;49:966–671.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.